These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33460214)

  • 21. Lyophilized growth factor intralesional injection in female pattern hair loss: A clinical and trichoscopic study.
    El Samahy MH; Fahmy HM; El Sawaf SI; Mostafa AE
    Dermatol Ther; 2021 Mar; 34(2):e14867. PubMed ID: 33570240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiandrogen treatment of polycystic ovary syndrome.
    Rittmaster RS
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of female pattern hair loss with oral antiandrogens.
    Sinclair R; Wewerinke M; Jolley D
    Br J Dermatol; 2005 Mar; 152(3):466-73. PubMed ID: 15787815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility.
    Rossi A; D'Arino A; Pigliacelli F; Caro G; Muscianese M; Fortuna MC; Carlesimo M
    Australas J Dermatol; 2019 Nov; 60(4):e279-e283. PubMed ID: 31168786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of Trimax-360 serum in healthy adult subjects with mild to moderate alopecia of scalp.
    Chew SK; Gajjar T; Sethi S
    J Cosmet Dermatol; 2022 Oct; 21(10):4536-4544. PubMed ID: 35435296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
    Olsen EA; Whiting DA; Savin R; Rodgers A; Johnson-Levonas AO; Round E; Rotonda J; Kaufman KD;
    J Am Acad Dermatol; 2012 Sep; 67(3):379-86. PubMed ID: 22325459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features.
    Quinn M; Shinkai K; Pasch L; Kuzmich L; Cedars M; Huddleston H
    Fertil Steril; 2014 Apr; 101(4):1129-34. PubMed ID: 24534277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injections of platelet-rich plasma for androgenic alopecia: A systematic review.
    Picard F; Hersant B; Niddam J; Meningaud JP
    J Stomatol Oral Maxillofac Surg; 2017 Oct; 118(5):291-297. PubMed ID: 28676455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss.
    Lee SH; Zheng Z; Kang JS; Kim DY; Oh SH; Cho SB
    Wound Repair Regen; 2015; 23(1):30-6. PubMed ID: 25524027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hair loss in women.
    Camacho-Martínez FM
    Semin Cutan Med Surg; 2009 Mar; 28(1):19-32. PubMed ID: 19341939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen excess: Investigations and management.
    Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of minoxidil on hair growth in androgenic alopecia in women].
    Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2002 Sep; 13(75):208-11. PubMed ID: 12474572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of hair follicle parameters using computer image analysis: a comparison of androgenetic alopecia with normal scalp biopsies.
    Lee MS; Kossard S; Wilkinson B; Doyle JA
    Australas J Dermatol; 1995 Aug; 36(3):143-7. PubMed ID: 7487740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome.
    Tu YA; Lin SJ; Chen PL; Chou CH; Huang CC; Ho HN; Chen MJ
    J Formos Med Assoc; 2019 Aug; 118(8):1225-1231. PubMed ID: 31056381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
    Rathnayake D; Sinclair R
    Dermatol Clin; 2010 Jul; 28(3):611-8. PubMed ID: 20510769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study.
    Anitua E; Pino A; Martinez N; Orive G; Berridi D
    Dermatol Surg; 2017 May; 43(5):658-670. PubMed ID: 28221183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.